Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Ibrutinib

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBMT1695

    12/30/2016

    A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplant versus Placebo In Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-cell Subtype

    Treatment

    VICCBMT1651

    09/30/2016

    Optimizing Post-Allogeneic Hematopoietic Cell Transplant Outcomes for Lymphoma Using Ibrutinib

    Treatment

    VICCGI15126

    05/03/2016

    A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors


    Print this page for your doctor